INDIAGLYCO Q4 FY25 Results & Concall Summary: Key Takeaways (INDIAGLYCO)

INDIAGLYCO Q4 FY25 (Mar-2025 Qtr) Earnings call highlights: Key takeaways, performance, financial metrics, outlook and guidance, concerns and management tone.

India Glycols Ltd (INDIAGLYCO) Q4FY25 Concall Summary - Mar-2025 Qtr

Performance Overview

  • India Glycols Ltd reported strong growth in Bio-Fuels (48% increase) and Potable Spirits (14.8% increase) during Q4 FY25.
  • EBITDA saw a significant rise of 35.1%, reaching INR 148 crores, with margins expanding by 532 basis points to 17.1%.
  • PAT for the quarter surged by 51.7% to INR 64 crores, with margins increasing by 287 basis points to 7.4%.
  • For the full year FY25, net revenue grew by 14.4% to INR 3,768 crores, driven by Potable Spirits (22.8% growth) and Bio-Fuels (103.7% growth).
  • The joint venture (JV) with Clariant also performed well, with net revenue up 13% and EBITDA up 70%.

Financial Metrics

Log in to Stocksigma to read the Financial Metrics section of this summary.

Operating Performance / Business Segments

Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.

Key Discussions & Insights

Log in to Stocksigma to read the Key Discussions & Insights section of this summary.

Outlook and Guidance

Log in to Stocksigma to read the Outlook and Guidance section of this summary.

Challenges / Concerns

Log in to Stocksigma to read the Challenges / Concerns section of this summary.

Industry / Competitive Landscape

Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.

Overall Summary

Log in to Stocksigma to read the Overall Summary section of this summary.